Investment Summary |
|
|---|---|
| Date | 2021-05-26 |
| Target | Engine Biosciences |
| Sector | Life Science |
| Investor(s) | Polaris Partners |
| Deal Type | Venture |
SEARCH BY
| Category | Growth Capital Firm |
|---|---|
| Founded | 1996 |
| PE ASSETS | 5.0B USD |
| Size | Large |
| Type | Sector Agnostic |
Polaris Partners is primarily a seed, first round, and early stage venture capital investor in information technology and life science businesses. However, Polaris also focuses on private equity investments in established companies. In this area, Polaris targets high growth middle market companies in industries including technology, healthcare, digital media, consumer products and services, and business services. The firm's investments include minority growth equity investments, recapitalizations with liquidity, and leveraged buyouts. Polaris Partners was formed in 1996 and has offices in Seattle, Washington and Waltham, Massachusetts.
| DEAL STATS | # |
|---|---|
| Overall | 71 of 87 |
| Sector: Life Science M&A | 26 of 39 |
| Type: Venture M&A Deals | 43 of 57 |
| Country: Singapore M&A | 2 of 3 |
| Year: 2021 M&A | 7 of 17 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-05-17 |
Hummingbird Bioscience
Singapore, Singapore Hummingbird Bioscience is an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets to improve treatment outcomes. Hummingbird Bioscience was founded in 2015 and is based in Singapore. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-05-27 |
August Bioservices
Nashville, Tennessee, United States August Bioservices is a quality-driven CDMO that offers end-to-end drug research and development, cGMP laboratory services, and sterile fill/finish cGMP manufacturing to clients of all sizes and stages, from pre-clinical to commercial, all under one roof. August Bioservices was founded in 2017 and is based in Nashville, Tennessee. |
Buy | - |
